Great Chinasoft Technology Co.,Ltd. cancelled the acquisition of 27% stake in ChinaTech Peptide Center Co., Ltd. from Suzhou Tianma Pharma Co., Ltd.
December 16, 2020
Share
Great Chinasoft Technology Co.,Ltd. (SZSE:002453) signed an agreement to acquire 27% stake in ChinaTech Peptide Center Co., Ltd. from Suzhou Tianma Pharma (Group) Co., Ltd on December 17, 2019. Transaction does not need the approvals of the Great Chinasoft Technology’s Directorate and Shareholders.
Great Chinasoft Technology Co.,Ltd. (SZSE:002453) cancelled the acquisition of 27% stake in ChinaTech Peptide Center Co., Ltd. from Suzhou Tianma Pharma (Group) Co., Ltd on December 17, 2020.
Great Chinasoft Technology Co., Ltd, formerly Suzhou Tianma Specialty Chemicals Co., Ltd., is a China-based company principally engaged in the research, development, manufacture and distribution of fine chemical products. The Company primarily provides paper making chemicals, including paper making sizing agent, alkyl ketene dimmer (AKD) raw powders and AKD emulsion; pharmaceutical intermediates, including amino acid protective agents and protected amino acids series products, pesticide intermediates, as well as phosgene derivatives and others. It is also engaged in the provision of phosgene processing services, as well as supply chain management and software development and sales businesses. The Company conducts its businesses in both domestic and overseas markets.
GREAT CHINASOFT TECHNOLOGY CO.,LTD. 
